CRISPR Therapeutics
CRSP
#3123
Rank
HK$30.59 B
Marketcap
HK$358.39
Share price
-2.56%
Change (1 day)
-36.28%
Change (1 year)

CRISPR Therapeutics (CRSP) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$2.46 Billion

According to CRISPR Therapeutics's latest financial reports the company's total liabilities are HK$2.46 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CRISPR Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$2.70 B-5.7%
2022-12-31HK$2.87 B4.51%
2021-12-31HK$2.74 B116.5%
2020-12-31HK$1.26 B28%
2019-12-31HK$0.99 B30.79%
2018-12-31HK$0.75 B16.2%
2017-12-31HK$0.65 B-24.95%
2016-12-31HK$0.86 B-40.51%
2015-12-31HK$1.46 B2116.29%
2014-12-31HK$65.93 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$0.20 B-91.62%๐Ÿ‡บ๐Ÿ‡ธ USA